M Marre, J Shaw, M Brandle, WM Bebakar, NA … - Diabetic Medicine, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 25 - Related articles - All 3 versions
JB Buse, J Rosenstock, G Sesti, WE Schmidt, … - The Lancet, 2009 - Elsevier Mean baseline HbA 1c for the study population was 8·2%. Liraglutide reduced
mean HbA 1c significantly more than did exenatide (−1·12% [SE 0·08] vs
−0·79% [0·08]; estimated treatment difference −0·33; 95% CI −0·47 ... Cited by 17 - Related articles - All 25 versions
J White - Journal of the American Pharmacists Association, 2009 - Am Pharmacists Assoc Increased understanding of the glucoregulatory action of ... At A Glance
Synopsis: Several incretin therapies are available for the treatment of patients
with type 2 diabetes; addi- tional agents are awaiting Food and Drug ... Cited by 4 - Related articles
JJ Neumiller - Journal of the American Pharmacists Association, 2009 - Am Pharmacists Assoc Type 2 diabetes is characterized by insulin resistance, a ... At A Glance
Synopsis: Incretin-based therapies are a relatively new option for the treatment
of patients with type 2 diabetes. These therapies hold promise in overcom- ... Cited by 4 - Related articles
JJ Holst, Y Seino - Diabetes Research and Clinical Practice, 2009 - Elsevier GLP-1 is rapidly degraded by the action of dipeptidyl peptidase-4 (DPP-4), which
results in an in vivo half-life of approximately 2 min. Thus, continuous
infusion of native GLP-1 would be required to maintain therapeutic ... Related articles - All 11 versions
MC Rossi, A Nicolucci - Acta bio-medica: Atenei Parmensis, 2009 - actabiomedica.it Type 2 diabetes mellitus (T2DM) is a global epi- demic and a leading cause of
morbidity and mortality that places a substantial economic and health burden on
the public (1). Successful management of T2DM requires strict control of ... Related articles - View as HTML - All 2 versions
DD'Alessio - webbasedcme.com Page 1. 1 The Importance of Postprandial Plasma Glucose Control Page 2 Measures
of glycemic control: Interpretation and use in clinical practice ... Related articles - View as HTML
J Wilding - The British Journal of Diabetes & Vascular Disease, 2009 - dvd.sagepub.com Page 1. http://dvd.sagepub.com Disease The British Journal of Diabetes &
Vascular DOI: 10.1177/1474651409342637 2009; 9; 177 British ... Related articles - All 2 versions
A Statements - medscape.com Robert R. Henry, MD Chief, VA Endocrinology & Metabolism, Professor of Medicine
in Residence, University of California, San Diego, La Jolla, California
Disclosures: Grant/Research Support: Amylin Pharmaceuticals Inc, ... Related articles - All 2 versions
